NEW YORK (GenomeWeb) - Veracyte today announced after the close of the market that revenues for its first quarter rose 50 percent on sales of its Afirma gene expression classifier (GEC) tests.

For the three months ended March 31, 2015, the South San Francisco, California-based molecular diagnostics company said that revenues increased to $11.2 million from $7.5 million a year ago, beating the average Wall Street expectation of $10.8 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.